Partnering Opportunities

Rexahn seeks to establish global and regional strategic alliances and partnerships that complement our expertise in oncology product development.

We continually review opportunities to in-license and advance compounds in oncology that have value-creating potential and will strengthen our clinical development pipeline.

Interested in Collaborating?

For more information about our products or to send us information about your products and technologies, please email us

Current Collaborators

Zhejiang Haichang Biotechnology Co., Ltd.

Zhejiang Haichang Biotechnology Co., Ltd. is a privately-owned specialized biotechnology company headquartered in Hangzhou, China, focused on the development and manufacture of complex intravenous pharmaceutical products including liposome and microsphere products, primarily for cancer treatment.

Learn More

Merck & Co.

Rexahn has entered into a collaboration agreement with Merck to evaluate RX-5902 in combination with Keytruda® in triple negative breast cancer TNBC.

Learn More